News | TCT | September 15, 2022

Valentin Fuster, M.D., Ph.D., Receives Prestigious Award from Cardiovascular Research Foundation

Dr. Valentin Fuster to be honored with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career Achievement Award. Image courtesy of Mount Sinai Health System

Dr. Valentin Fuster to be honored with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career Achievement Award. Image courtesy of Mount Sinai Health System 


September 15, 2022 — The Cardiovascular Research Foundation (CRF) will honor Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, with the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Career Achievement Award

Dr. Fuster will receive this award September 17, at the 34th annual TCT scientific symposium, sponsored by CRF. The TCT Career Achievement award recognizes Dr. Fuster’s extraordinary contributions to the field of interventional cardiology and transformation of patient care through his career endeavors, research pursuits, and mentorship of others.
“I am grateful for this award and would like to recognize all the contributors who have inspired my work,” says Dr. Fuster.
Dr. Fuster's contributions to cardiovascular medicine and the prevention and treatment of heart disease globally are unparalleled. He has 35 worldwide honorary degrees and is the most highly cited Spanish research scientist of all time, according to Google Scholar. He is an author of more than 900 scientific articles in international medical journals and has published two leading books on clinical cardiology and research. Dr. Fuster has received three of the most important awards from the National Institutes of Health and is the only cardiologist to have received the highest awards for research from the four leading international cardiology organizations: the American College of Cardiology, American Heart Association (AHA), European Society of Cardiology, and Interamerican Society of Cardiology. He recently received Thailand’s Prince Mahidol Award in the field of Medicine, and this year, the AHA established the “Valentin Fuster Award for Innovation in Science” in his honor, naming him the first recipient. 

Dr. Fuster is Editor-in-Chief of the Journal of the American College of Cardiology (JACC), which ranks among the top cardiovascular journals in the world for its scientific impact. He is a past president of both the AHA and the World Heart Federation. He the General Director of the Spanish National Center for Cardiovascular Research (CNIC).  Dr. Fuster is a member of the National Academy of Medicine, where he served as chair of the Committee on Preventing the Global Epidemic of Cardiovascular Disease, and was a Council member of the National Heart, Lung, and Blood Institute. Dr. Fuster was also President of the Training Program of the American College of Cardiology. 

For more information: https://www.mountsinai.org 

Find more TCT22 coverage here  


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now